TrialsgrambetaRCTs are beautiful

PROTECTED TAVR

2022

Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement

In 3,000 patients undergoing transcatheter aortic-valve replacement, the Sentinel cerebral embolic protection device did not reduce periprocedural stroke compared with no embolic protection.

Result

Stroke within 72 hours of TAVR or before discharge
Absolute difference
0.6 points
Effect estimate

difference-0.695% CI -1.7 to 0.5 · P = 0.30

The absolute difference is derived from the event rates.

Also reported: Neutral. Disabling stroke numerically lower (0.5% vs 1.3%) but exploratory.

Original publication
Subtopic
cerebral embolic protection
Design
Multicentre RCT
Relevance
Supporting: context rather than must-know.
Source
Kapadia SR, et al. N Engl J Med. 2022;387(14):1253-63.doi 10.1056/NEJMoa2204961

Discussion & critique

Observed overall stroke rate (~2.5%) far below the assumed 4%, leaving the trial underpowered; disabling-stroke signal only hypothesis-generating. Did not establish routine embolic protection.

Discussed in podcasts